Cantel Medical (CMD) Stock Price, News & Analysis

Company Overview

Cantel Medical Corp. provides infection prevention and control products and services for the healthcare market. The company's Medical segment offers automated endoscope reprocessing systems; disinfectants and sterilants; detergents; leak testing and manual cleaning products; storage cabinets and transport systems; manual cleaning products; endoscope process tracking products; other consumables, accessories, and supplies for use in disinfect rigid endoscopes, flexible endoscopes, and other instrumentation; and technical maintenance services. Its Life Sciences segment provides dialysis water purification and bicarbonate mixing systems; hollow fiber filters, and other filtration and separation products; liquid disinfectants and cold sterilization products; dry fog products; room temperature sterilization equipment and services; and clean-room certification and decontamination services for the dialysis and other healthcare, research laboratories, food and beverage, and commercial industrial customers, as well as microbiological testing services. The company's Dental segment offers hand and powered dental instruments, instrument reprocessing and sterility assurance products, towels, bibs, tray liners, sponges, nitrous oxide/oxygen sedation equipment and related single-use disposable nasal masks, face masks, and shields. It also provides hand sanitizers, germicidal wipes, disinfectants, surface disinfectants, waterline treatment products, saliva ejectors, evacuator tips, plastic cups, prophy angles, and prophy paste. The company's Dialysis segment provides hemodialysis concentrates and other ancillary supplies; medical device reprocessing systems; and sterilants and disinfectants. The company sells its products through its direct distribution network in the United States; and directly or under various third-party distribution agreements internationally. Cantel Medical Corp. was founded in 1963 and is headquartered in Little Falls, New Jersey.

Key Stats

• Today's Range: $80.37 to $80.37
• 50-Day Range: $80.37 to $88.79
• 52-Week Range: $39.40 to $89.76
• Volume: N/A
• Average Volume: 626,604 shs
• Market Capitalization: $3.58 billion
• P/E Ratio: 69.28
• Dividend Yield: 0.26%
• Price Target: N/A
• Consensus Rating: N/A

Cantel Medical Stock Analysis - MarketRank™

Cantel Medical scored higher than 29% of companies evaluated by MarketBeat, and ranked 811th out of 956 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: N/A
• Analyst Rating: N/A

Consensus Rating

There is not enough analysis data for Cantel Medical.

Earnings and Valuation

• Score: 0.6 / 5
• Proj. Earnings Growth: 6.11%

Earnings Growth

Earnings for Cantel Medical are expected to grow by 6.11% in the coming year, from $2.62 to $2.78 per share.

Price to Earnings Ratio vs. the Market

The P/E ratio of Cantel Medical is 69.28, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 23.71.

Price to Earnings Ratio vs. Sector

The P/E ratio of Cantel Medical is 69.28, which means that it is trading at a more expensive P/E ratio than the Medical sector average P/E ratio of about 26.81.

Price to Earnings Growth Ratio

Cantel Medical has a PEG Ratio of 1.63. PEG Ratios above 1 indicate that a company could be overvalued.

Price to Book Value per Share Ratio

Cantel Medical has a P/B Ratio of 4.64. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

Short Interest

• Score: N/A
• Short Interest Level: N/A

Short Interest

There is no current short interest data available for CMD.

Dividend

• Score: 1.7 / 5
• Dividend Strength: Weak

Dividend Yield

Cantel Medical has a dividend yield of 0.26%, which is in the bottom 25% of all stocks that pay dividends.

Dividend Growth

Cantel Medical does not have a long track record of dividend growth.

Dividend Coverage

The dividend payout ratio of Cantel Medical is 12.73%. This payout ratio is at a healthy, sustainable level, below 75%.

Dividend Sustainability

Based on earnings estimates, Cantel Medical will have a dividend payout ratio of 7.55% next year. This indicates that Cantel Medical will be able to sustain or increase its dividend.

Sustainability and ESG

• Score: 4.1 / 5
• Environmental Score: -1.60

Short Interest

There is no current short interest data available for CMD.

News and Social Media

• Score: 0.6 / 5
• News Sentiment: N/A

Search Interest

1 people have searched for CMD on MarketBeat in the last 30 days.

Company Ownership

• Score: 2.5 / 5
• Insider Trading: N/A

Insider Buying vs. Insider Selling

In the past three months, Cantel Medical insiders have not sold or bought any company stock.

Percentage Held by Insiders

10.70% of the stock of Cantel Medical is held by insiders. A high percentage of insider ownership can be a sign of company health.

Percentage Held by Institutions

84.13% of the stock of Cantel Medical is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

CMD Stock Analysis - Frequently Asked Questions

How were Cantel Medical's earnings last quarter?

Cantel Medical Corp. (NYSE:CMD) released its quarterly earnings results on Monday, March, 8th. The company reported $0.79 EPS for the quarter, beating analysts' consensus estimates of $0.50 by $0.29. The firm's revenue was up 1.9% compared to the same quarter last year.

What other stocks do shareholders of Cantel Medical own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Cantel Medical investors own include Meta Platforms (META), NVIDIA (NVDA), M&T Bank (MTB), Johnson & Johnson (JNJ), Lam Research (LRCX), Pfizer (PFE) and Exxon Mobil (XOM).

Company Calendar

• Last Earnings: 3/08/2021
• Today: 2/23/2025

Industry, Sector and Symbol

• Stock Exchange: NYSE
• Sector: Medical
• Industry: Surgical & Medical Instruments
• Sub-Industry: N/A
• Current Symbol: NYSE:CMD
• CUSIP: N/A
• CIK: 19446
• Web: www.cantelmedical.com
• Phone: 973-890-7220
• Fax: N/A
• Employees: 3,669
• Year Founded: N/A

Profitability

• EPS (Most Recent Fiscal Year): $1.65
• Trailing P/E Ratio: 69.28
• Forward P/E Ratio: 30.68
• P/E Growth: 1.63
• Net Income: $13.71 million
• Net Margins: 4.72%
• Pretax Margin: N/A
• Return on Equity: 12.13%
• Return on Assets: 4.45%

Debt

• Debt-to-Equity Ratio: 1.16
• Current Ratio: 2.72
• Quick Ratio: 2.00

Sales & Book Value

• Annual Sales: $1.02 billion
• Price / Sales: 3.52
• Cash Flow: $3.38 per share
• Price / Cash Flow: 23.78
• Book Value: $17.31 per share
• Price / Book: 4.64

Miscellaneous

• Outstanding Shares: 44,513,000
• Free Float: N/A
• Market Cap: $3.58 billion
• Optionable: Optionable
• Beta: 1.55